Action Programed Nanoantibiotics with pH‐Induced Collapse and Negative‐Charged‐Surface‐Induced Deformation Against Antibiotic‐Resistant Bacterial Peritonitis
Xiao Zhang,Penghui Liu,Ran Zhang,Wenhong Zheng,Di Qin,Yinghang Liu,Xin Wang,Tongyi Sun,Yuanyuan Gao,Li‐Li Li
DOI: https://doi.org/10.1002/adhm.202401470
IF: 10
2024-06-27
Advanced Healthcare Materials
Abstract:The incorporation of well‐designed antibiotic nanocarriers, along with an antibiotic adjuvant effect, in combination with various antibiotics, offers us an opportunity to combat drug‐resistant strains. However, precise control over morphology and encapsulated payload release can significantly impact their antibacterial efficacy and synergistic effects when used alongside antibiotics. Here, we focus on developing lipopeptide‐based nano‐antibiotics, which demonstrate an antibiotic adjuvant effect by inducing pH‐induced collapse and negative‐charged‐surface‐induced deformation. This enhances the disruption of the bacterial outer membrane and facilitates drug penetration, effectively boosting the antimicrobial activity against drug‐resistant strains. The modulation regulations of the lipopeptide nanocarriers with modular design were governed by us. The nanoantibiotics, made from lipopeptide and ciprofloxacin (Cip), have a drug loading efficiency of over 80%. The combination with Cip resulted in a significantly low fractional inhibitory concentration index (FIC) of 0.375 and a remarkable reduction in the minimum inhibitory concentration (MIC) of Cip against MDR E. coli (clinical isolated strains) by up to 32‐fold. The survival rate of MDR E. coli peritonitis treated with our nanoantibiotics was significantly higher, reaching over 87%, compared to only 25% for Cip and no survival for the control group. Meanwhile, the nanoantibiotic showed no obvious toxicity to major organs. This article is protected by copyright. All rights reserved
nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials